Last edition
News about "Heron Therapeutics "
Heron Therapeutics Gets FDA Approval for ZYNRELEF VAN
The VAN will replace the current vented vial spike and has the potential to simplify aseptic preparation, while also significantly reducing ZYNRELEF's withdrawal time down to between twenty and forty-five seconds.
Heron Therapeutics | 26/09/2024 | By Aishwarya | 175
Heron Therapeutics Announces Acceptance of the PAS Application for ZYNRELEF
Heron Therapeutics, Inc. has announced that the FDA acknowledged the receipt of the company's Prior Approval Supplement (PAS) application for ZYNRELEF (bupivacaine and meloxicam) extended-release solution VAN.
Heron Therapeutics | 04/07/2024 | By Aishwarya | 199
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy